Pfizer Inc (PFE): PFE/MRNA—1Q24 COVID-vaccine worldwide

Next 10 Prev Next

Send PM Follow Ignore

Re: DewDiligence post# 6088

Thursday, 05/02/2024 1:24:05 PM

Thursday, May 02, 2024 1:24:05 PM

PFE/MRNA—1Q24 COVID-vaccine worldwide_market_share—>68/32 in favor of PFE.

https://www.accesswire.com/858697/moderna-reports-first-quarter-2024-financial-results-and-provides-business-updates

PFE’s 2024 guidance for Comirnaty sales is $5.0B (#msg-174337807); MRNA has not issued 2024 guidance for Spikevax, but rather for total corporate revenue including the not-yet-approved RSV vaccine.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Next 10 Prev Next

Go Ad-Free